Natural Alternatives International Inc. (NASDAQ:NAII) CEO Mark A. Ledoux sold 6,992 shares of the stock in a transaction dated Tuesday, November 22nd. The shares were sold at an average price of $13.27, for a total value of $92,783.84. Following the completion of the sale, the chief executive officer now directly owns 73,012 shares of the company’s stock, valued at approximately $968,869.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Shares of Natural Alternatives International Inc. (NASDAQ:NAII) remained flat at $13.20 during midday trading on Thursday. 43,465 shares of the stock traded hands. Natural Alternatives International Inc. has a 1-year low of $6.72 and a 1-year high of $14.50. The company has a market cap of $86.57 million, a PE ratio of 8.09 and a beta of -0.51. The stock has a 50-day moving average of $13.00 and a 200-day moving average of $11.67.

Insider Buying and Selling by Quarter for Natural Alternatives International (NASDAQ:NAII)

COPYRIGHT VIOLATION NOTICE: “Natural Alternatives International Inc. (NAII) CEO Mark A. Ledoux Sells 6,992 Shares” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark legislation. The original version of this news story can be accessed at https://www.thecerbatgem.com/2016/11/24/natural-alternatives-international-inc-naii-ceo-mark-a-ledoux-sells-6992-shares.html.

Natural Alternatives International Company Profile

Natural Alternatives International, Inc is a formulator, manufacturer and marketer of nutritional supplements. The Company operates through three segments: private-label contract manufacturing, which provides manufacturing services to companies that market and distribute nutritional supplements and other healthcare products; patent and trademark licensing, which includes direct raw material sales and royalty income from its license and supply agreements associated with the sale and use of beta-alanine under its CarnosSyn trade name, and branded products, which markets and distributes branded nutritional supplements and consists primarily of the products sold under its Pathway to Healing product line.

5 Day Chart for NASDAQ:NAII

Receive News & Stock Ratings for Natural Alternatives International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natural Alternatives International Inc. and related stocks with our FREE daily email newsletter.